This statistic depicts the global top 10 companies for cardiology-related drug sales in 2023 and a forecast for 2028. In 2023, Novartis generated 7.8 billion U.S. dollars of heart drug revenues worldwide. The Swiss company is projected to keep its leading position in this field until 2028. Cardiovascular diseases are amomng the most common causes of death in general. Risk for heart disease increases with diabetes, obesity, poor diet, and a lack of physical activity.
Global leading 10 pharmaceutical companies based on cardiovascular revenue in 2023 and a forecast for 2028
(in billion U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Evaluate Vantage. (August 3, 2023). Global leading 10 pharmaceutical companies based on cardiovascular revenue in 2023 and a forecast for 2028 (in billion U.S. dollars) [Graph]. In Statista. Retrieved December 25, 2024, from https://www.statista.com/statistics/1448707/top-global-pharma-companies-by-cardiology-revenues/
Evaluate Vantage. "Global leading 10 pharmaceutical companies based on cardiovascular revenue in 2023 and a forecast for 2028 (in billion U.S. dollars)." Chart. August 3, 2023. Statista. Accessed December 25, 2024. https://www.statista.com/statistics/1448707/top-global-pharma-companies-by-cardiology-revenues/
Evaluate Vantage. (2023). Global leading 10 pharmaceutical companies based on cardiovascular revenue in 2023 and a forecast for 2028 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: December 25, 2024. https://www.statista.com/statistics/1448707/top-global-pharma-companies-by-cardiology-revenues/
Evaluate Vantage. "Global Leading 10 Pharmaceutical Companies Based on Cardiovascular Revenue in 2023 and a Forecast for 2028 (in Billion U.S. Dollars)." Statista, Statista Inc., 3 Aug 2023, https://www.statista.com/statistics/1448707/top-global-pharma-companies-by-cardiology-revenues/
Evaluate Vantage, Global leading 10 pharmaceutical companies based on cardiovascular revenue in 2023 and a forecast for 2028 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/1448707/top-global-pharma-companies-by-cardiology-revenues/ (last visited December 25, 2024)
Global leading 10 pharmaceutical companies based on cardiovascular revenue in 2023 and a forecast for 2028 (in billion U.S. dollars) [Graph], Evaluate Vantage, August 3, 2023. [Online]. Available: https://www.statista.com/statistics/1448707/top-global-pharma-companies-by-cardiology-revenues/
